Daily COVID-19 cases in the U.S. are projected to jump 80% in the next 2 weeks, according to forecasts from the Mayo Clinic. (Becker’s Hospital Review)
Most U.S. COVID deaths are occurring in older adults, with 9 out of 10 fatalities in people age 65 and up. (Washington Post)
After protests broke out in China over COVID lockdowns, the country eased some virus restrictions but maintained its “zero-COVID” strategy. (PBS)
Chinese authorities have started inquiries into people who attended protests against the COVID lockdowns. (Reuters)
Shanghai Disneyland announced it will remain temporarily closed to comply with COVID prevention measures. (Reuters)
Surgeons in Ukraine operated on a patient in the dark using only a flashlight after Russia unleashed a missile barrage on the nation’s power grid. (NBC News)
Pharma industry groups and CVS Health expressed skepticism over a plan proposed by the FDA that would allow certain generic drugs to pick up over-the-counter indications. (Endpoints News)
Marketing biosimilars with skinny labels — labels for biosimilars or generics that include a smaller set of indications than the brand-name drugs — saved Medicare $1.5 billion from 2015 to 2020, 5% of what it spent on five biologics during that period. (JAMA Internal Medicine)
Flu hospitalizations are up nearly 30% from last week, as scientists and public health experts express concern about the virus spreading during holiday gatherings. (CNBC)
As the CDC prepares to announce nearly $4 billion to improve public health infrastructure, most of which will be allocated to local health departments, community-based health groups say they’re being left out of funding. (CNN)
A doctor in the San Francisco area pleaded guilty to using misbranded products that she sold as genuine Botox and Juvederm, the Department of Justice announced.
Houston lifted the boil water notice it had issued after a power outage led water pressure levels to dip below safe levels. (Houston Chronicle)
Roche Pharmaceuticals has withdrawn the U.S. indication for atezolizumab (Tecentriq) to treat a form of bladder cancer, after a clinical trial failed and the drug could not move from accelerated to regular approval.
The U.S. is looking to developing countries for a new paradigm of mental health care. (Vox)
A resurgence of polio cases in Indonesia has sparked a mass vaccination campaign in the country. (AP)